Epigenetic regulation of microRNAs in neurogenesis
microRNA在神经发生中的表观遗传调控
基本信息
- 批准号:7738740
- 负责人:
- 金额:$ 23.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-09-29
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAdverse effectsAffectAntibodiesBipolar DisorderCell Differentiation processCellsChromatinComplementComplexDevelopmentEpigenetic ProcessEpilepsyEvaluationGene ExpressionGenesGenomeGlial Fibrillary Acidic ProteinHistone DeacetylaseHistone Deacetylase InhibitorHistone deacetylase inhibitionHistonesIndividualMeasuresMediatingMessenger RNAMicroRNAsMigraineNeuronal DifferentiationNeuronsNucleic Acid Regulatory SequencesParkinson&aposs DementiaPharmaceutical PreparationsProductionPromoter RegionsRNARegulationScreening procedureSiteSmall RNAStrokeTechniquesTechnologyTestingadult neurogenesisadult stem celldesigninhibitor/antagonistnerve stem cellnestin proteinneural precursor cellneurogenesisnovelpromoterprotein expressionpublic health relevancerelating to nervous systemresearch studyvalproate
项目摘要
DESCRIPTION (provided by applicant): Epigenetic regulation of microRNAs in neurogenesis Histone deacetylase (HDAC) inhibitors such as valproate (VPA) are commonly used to treat epilepsy. One me- chanism of their efficacy may result from epigenetic effects on differentiation of neural precursors. While HDAC inhibitors are likely to affect mRNA-encoding genes, we believe that the rapid regulation of microRNAs by VPA treatment suggests a novel complementary mechanism. Hypothesis: Acetylated histones allow expression of microRNAs that enhance or support neurogenesis from neural precursors. Therefore, adding an HDAC inhibitor allows the accumulation of acetyl marks on microRNA-encoding sites on the chromatin, in turn enhancing expression of the marked microRNAs, which contribute to neural differentiation. We will test the hypothesis by using "deep sequencing" to identify the full complement of VPA-regulated microRNAs, including hundreds of novel microRNAs that we recently identified in neural differentiation. Finally, we will build on our preliminary studies with microRNA inhibitors and screening techniques to evaluate candidate microRNAs for their requirement for VPA-induced neuronal differentiation. Results from these three aims will identify both known and putatively novel microRNAs that are regulated after HDAC inhibition, the acetylation status of histones located near microRNA promoter regions, and whether the regulated microRNAs contribute to neuronal differentiation. Understanding the regulatory networks required for neurogenesis is important for determining how differentiation of neural precursors could be impaired in conditions such as dementia, Parkinson's, or stroke. Alternatively, the use of HDAC inhibitors in conditions such as epilepsy, bipolar disorder, or migraines may have unexpected effects on neurogenesis from adult precursors, and this potential benefit should be understood. PUBLIC HEALTH RELEVANCE: Epigenetic regulation of microRNAs in neurogenesis. Epilepsy drugs such as valproate (VPA) are known to inhibit histone deacetylases, which control gene expression epigenetically. Since VPA also increases the production of neurons from adult stem cells or other precursors, we believe that VPA may regulate microRNA genes, in turn affecting decisions controlling cell differentiation. We will use "deep sequencing" of microRNAs and gene regulatory regions to identify novel neurogenesis mechanisms.
描述(由申请人提供):神经发生组蛋白脱乙酰基酶(HDAC)抑制剂(如丙戊酸)(VPA)的表观遗传调节通常用于治疗癫痫。它们的功效的一种我可能是由于对神经前体的分化的表观遗传作用而引起的。尽管HDAC抑制剂可能会影响mRNA编码基因,但我们认为通过VPA处理对microRNA的快速调节表明了一种新型的互补机制。假设:乙酰化组蛋白允许表达microRNA,从而增强或支持神经前体神经发生。因此,添加HDAC抑制剂允许在染色质上的microRNA编码位点上积聚乙酰标记,从而增强了标记的microRNA的表达,从而有助于神经分化。我们将通过使用“深层测序”来检验假设,以确定VPA调节的microRNA的完整补体,包括我们最近在神经分化中发现的数百种新型microRNA。最后,我们将以microRNA抑制剂和筛查技术的初步研究为基础,以评估候选microRNAS对VPA诱导的神经元分化的需求。这三个目标的结果将确定HDAC抑制后受调节的已知和新颖的microRNA,位于microRNA启动子区域附近的组蛋白的乙酰化状态以及调节的microRNA是否有助于神经元分化。了解神经发生所需的调节网络对于确定在痴呆症,帕金森氏症或中风等条件下如何损害神经前体的分化很重要。或者,在癫痫,躁郁症或偏头痛等条件下使用HDAC抑制剂可能会对成人前体的神经发生产生意外影响,因此应了解这种潜在的益处。公共卫生相关性:神经发生中microRNA的表观遗传调节。已知癫痫药物(例如丙戊酸)(VPA)抑制组蛋白脱乙酰基酶,这些乙酰基酶表观遗传控制基因表达。由于VPA还增加了成人干细胞或其他前体的神经元的产生,因此我们认为VPA可能调节microRNA基因,进而影响控制细胞分化的决策。我们将使用microRNA和基因调节区域的“深度测序”来鉴定新的神经发生机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD P HART其他文献
RONALD P HART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD P HART', 18)}}的其他基金
Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort
不同 GPC 队列中精神分裂症相关罕见变异的细胞后果和趋同生物学
- 批准号:
10672460 - 财政年份:2022
- 资助金额:
$ 23.05万 - 项目类别:
Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort
不同 GPC 队列中精神分裂症相关罕见变异的细胞后果和趋同生物学
- 批准号:
10539615 - 财政年份:2022
- 资助金额:
$ 23.05万 - 项目类别:
Modeling HIV-associated neurocognitive disorders and encephalopathy in human iPSC brain organoids containing microglia
在含有小胶质细胞的人 iPSC 脑类器官中模拟 HIV 相关的神经认知障碍和脑病
- 批准号:
10266193 - 财政年份:2020
- 资助金额:
$ 23.05万 - 项目类别:
Modeling HIV-associated neurocognitive disorders and encephalopathy in human iPSC brain organoids containing microglia
在含有小胶质细胞的人 iPSC 脑类器官中模拟 HIV 相关的神经认知障碍和脑病
- 批准号:
10161236 - 财政年份:2020
- 资助金额:
$ 23.05万 - 项目类别:
Developing an In Vitro Neurocircuitry Model of Addiction using Risk-Associated Hu
使用风险相关 Hu 开发成瘾的体外神经回路模型
- 批准号:
8633033 - 财政年份:2013
- 资助金额:
$ 23.05万 - 项目类别:
Developing an In Vitro Neurocircuitry Model of Addiction using Risk-Associated Hu
使用风险相关 Hu 开发成瘾的体外神经回路模型
- 批准号:
8703272 - 财政年份:2013
- 资助金额:
$ 23.05万 - 项目类别:
Developing an In Vitro Neurocircuitry Model of Addiction using Risk-Associated Hu
使用风险相关 Hu 开发成瘾的体外神经回路模型
- 批准号:
8533520 - 财政年份:2013
- 资助金额:
$ 23.05万 - 项目类别:
Phenotypic analysis of human iPSC carrying addiction-associated gene variants
携带成瘾相关基因变异的人类 iPSC 表型分析
- 批准号:
8331492 - 财政年份:2011
- 资助金额:
$ 23.05万 - 项目类别:
Phenotypic analysis of human iPSC carrying addiction-associated gene variants
携带成瘾相关基因变异的人类 iPSC 表型分析
- 批准号:
8250138 - 财政年份:2011
- 资助金额:
$ 23.05万 - 项目类别:
Genome-wide chromatin modification targeting by endogenous small RNAs
内源性小RNA靶向的全基因组染色质修饰
- 批准号:
7830428 - 财政年份:2010
- 资助金额:
$ 23.05万 - 项目类别:
相似国自然基金
基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
- 批准号:51009131
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
- 批准号:50178004
- 批准年份:2001
- 资助金额:23.0 万元
- 项目类别:面上项目
相似海外基金
Isoform Specific Histone Deacetylase Inhibitor Treatment in a Swine Model of Polytrauma and Sepsis
异构体特异性组蛋白脱乙酰酶抑制剂治疗多发伤和脓毒症猪模型
- 批准号:
9794007 - 财政年份:2018
- 资助金额:
$ 23.05万 - 项目类别:
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis
PPARgamma 脱乙酰化在恢复代谢稳态中的作用
- 批准号:
10182582 - 财政年份:2017
- 资助金额:
$ 23.05万 - 项目类别:
The Role of C-Kit Positive Cardiac Progenitors in Maternal Diabetes-Induced Heart Defects and the Therapeutic Values of These Cells
C-Kit 阳性心脏祖细胞在母亲糖尿病引起的心脏缺陷中的作用以及这些细胞的治疗价值
- 批准号:
9403962 - 财政年份:2017
- 资助金额:
$ 23.05万 - 项目类别:
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis
PPARgamma 脱乙酰化在恢复代谢稳态中的作用
- 批准号:
10302265 - 财政年份:2017
- 资助金额:
$ 23.05万 - 项目类别:
PPARgamma Deacetylation in the Restoration of Metabolic Homeostasis
PPARgamma 脱乙酰化在恢复代谢稳态中的作用
- 批准号:
10064620 - 财政年份:2017
- 资助金额:
$ 23.05万 - 项目类别: